why choose us

First received: July 26, 2022

Clinical Trial: Observational Lung Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform

Study Status: Completed

Recruit Status: RECRUITING

Condition: Non Small Cell Lung Cancer

Study Type: OBSERVATIONAL


Official Title: Observational Lung Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform (CYBRID-01)

Brief Summary: The primary objective of this study is to determine the ex-vivo prognostic accuracy of the Cybrid live tumor diagnostic platform using in-vivo RECIST 1.1 as the reference method.

Read more